Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

A Rocket Pharmaceuticals executive sold 1,224 shares of common stock to cover tax obligations related to the vesting of restricted stock units.

Summary

• John Militello, a Vice President at Rocket Pharmaceuticals, sold 1,224 shares of common stock on November 21, 2024.
• The sale was executed at a price of $13.054 per share.
• This transaction was to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
• Following the transaction, Militello directly owns 49,310 shares of Rocket Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Management Comments

• The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• This type of transaction is not unusual and is generally considered a normal part of executive compensation.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is generally considered a normal part of executive compensation.

Key Dates

Keywords

Rocket Pharmaceuticals, stock sale, insider trading, Form 4, executive, John Militello, restricted stock units, tax obligations